Blume Capital Management »

Immunitybio shares owned by Blume Capital Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Blume Capital Management from 13F filings

Historical chart of Blume Capital Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Blume Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Blume Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $20k 2.3k 8.76

More positions owned by Blume Capital Management

Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Apple (AAPL)
Vanguard Instl Index 0 3 Mo Tr Bi Etf (VBIL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Applied Materials (AMAT)
Citigroup Com New (C)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Amazon (AMZN)
Dimensional Etf Trust Core Fixe In Etf (DFCF)
Select Sector Spdr Tr St Str Energ Etf (XLE)
Charles Schwab Corporation (SCHW)
Freeport Mcmoran CL B (FCX)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)

View all positions for Blume Capital Management

Top funds holding Immunitybio

BlackRock
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
D. E. Shaw & Co
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Millennium Management
LMR Partners
Morgan Stanley
Northern Trust
Goldman Sachs Group
UBS Group

View all funds holding Immunitybio